In hepatocellular carcinoma, even malignant peripheral nerve sheath tumors (MPNSTs), CDK4/6is cause tumors to be more sensitive to PD-L1 blockade therapy by increasing the expression of PD-L1 [43,80]. Here, CDK4 is linked to malignant peripheral nerve sheath tumor.